Home › Calculator › DSNKY Dividend Calculator 2026
DSNKY Dividend DRIP Calculator 2026
2.58% YieldHealthcareDaiichi Sankyo Company, Limited · OTC
Price: $17.71 · Annual div: $0.46/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Calculator settings
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When DSNKY pays your bills
Year your monthly dividend income covers each expense (based on current settings)
Share your DSNKY snowball 📈
$10,000 in DSNKY → $13.21M in 10 years · $27,661.36/month
About Daiichi Sankyo Company, Limited (DSNKY) — Dividend Analysis 2026
Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise that encompasses the entire lifecycle of drug development, from pioneering research and development to manufacturing, importation, marketing, and worldwide distribution of its medicinal products. Its extensive and diverse portfolio features numerous key pharmaceutical offerings: Oncology: This includes trastuzumab deruxtecan (an anti-HER2 antibody-drug conjugate for cancer treatment), gefitinib for malignant tumors, bicalutamide for prostate cancer, and tamoxifen, an anti-breast cancer agent. Cardiovascular and Metabolic Health: The company provides teneligliptin and a combination of teneligliptin/canagliflozin for managing type 2 diabetes mellitus, along with colesevelam for both hypercholesterolemia and type 2 diabetes. Other notable products in this area are prasugrel, an antiplatelet agent; edoxaban, an anticoagulant; olmesartan, an antihypertensive; and pravastatin for hypercholesterolemia. Neurology and Pain Management: Offerings include mirogabalin for pain relief, lacosamide as an anti-epileptic agent, memantine for Alzheimer's disease, and loxoprofen, an anti-inflammatory analgesic. Bone Health: Denosumab is available for conditions like osteoporosis and other bone disorders. Gastrointestinal and Other Specialized Treatments: This category features esomeprazole for ulcer treatment, silodosin for dysuria, and ferric carboxymaltose and iron sucrose injections to address anemia. Infectious Diseases and Immunology: Daiichi Sankyo markets laninamivir for anti-influenza treatment, levofloxacin as an antibacterial agent, and a range of vaccines including adsorbed cell culture-derived influenza, influenza HA, measles rubella combined, and mumps vaccines. Beyond prescription medications, the company also supplies a variety of consumer healthcare products: Over-the-Counter Remedies: Lulu, a combination cold remedy, and Loxonin S, an antipyretic/anti-inflammatory analgesic. Dermatology and Personal Care: Transino, aimed at improving melasma and treating spots/freckles; Minon skincare products; and oral care solutions like Breath Labo and Clean Dental. Furthermore, Daiichi Sankyo's operations extend to pharmaceuticals and drugs for animals, cosmetics, medical equipment, various food products, drinking water, and active pharmaceutical ingredients (APIs) and intermediates. The company is also engaged in strategic collaborations, notably with Guardant Health to develop Guardant360 CDx, a companion diagnostic specifically for Enhertu in patients with advanced metastatic non-small cell lung cancer. Established in 1899, Daiichi Sankyo Company, Limited maintains its corporate headquarters in Tokyo, Japan.
Compare DSNKY with similar stocks
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full DSNKY DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open DSNKY position with:
🌍 DSNKY Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold DSNKY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 2.58% | -0.22% | $258 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 2.19% | -0.61% | $219 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 2.06% | -0.74% | $206 / yr |
| 🇬🇧 UK ISA | 0% | 2.58% | -0.22% | $258 / yr |
| 🇬🇧 UK Taxable | 8.75% | 2.35% | -0.45% | $235 / yr |
| 🇨🇦 TFSA | 0% | 2.58% | -0.22% | $258 / yr |
| 🇨🇦 CA Taxable | 25% | 1.94% | -0.86% | $194 / yr |
| 🇦🇺 Super (pension) | 15% | 2.19% | -0.61% | $219 / yr |
| 🇦🇺 AU Taxable | 30% | 1.81% | -0.99% | $181 / yr |
| 🇩🇪 DE Taxable | 26.375% | 1.90% | -0.90% | $190 / yr |
| 🇫🇷 FR Taxable | 30% | 1.81% | -0.99% | $181 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 DSNKY Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $0.46/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 DSNKY Dividend Payment Schedule
DSNKY pays quarterly — 4 times per year. Next ex-div: TBD.
📊 DSNKY vs Healthcare Benchmarks
How DSNKY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for DSNKY sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ DSNKY Insider Activity
No recent SEC filings reported in the last 90 days.Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the DSNKY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Daiichi Sankyo Company, Limited (DSNKY) is currently trading at $17.71, 56% below its 52-week high. The current dividend yield is 2.58% based on an annual payout of $0.46 per share.
DSNKY (Daiichi Sankyo Company, Limited) — 2.58% Dividend Yield Analysis
Daiichi Sankyo Company, Limited (DSNKY) is a healthcare stock currently trading at $17.71 with a dividend yield of 2.58%. The company pays an annual dividend of $0.46 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings. Over the past 5 years, DSNKY has grown its dividend at a compound annual rate of 100.0%.
- Dividend payments are not guaranteed and can be reduced or suspended at any time.
Auto-generated from live market data. For educational purposes only — not financial advice.